AIM ImmunoTech Inc (AIM) insider trading
Every open-market stock purchase and sale by AIM ImmunoTech Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Thomas K Equels (CEO), $824, 16 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $0.40 on Jun 9, 2026.
Recent AIM insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Mar 12, 2026 | Thomas K Equels (CEO) | Bought (not open market) | — |
| Mar 12, 2026 | David I. Chemerow (Director) | Bought (not open market) | — |
| Mar 12, 2026 | David I. Chemerow (Director) | Bought (not open market) | — |
| Mar 12, 2026 | Thomas K Equels (CEO) | Bought (not open market) | — |
| Mar 6, 2026 | Thomas K Equels (CEO) | Bought (not open market) | $625K |
| Mar 6, 2026 | David I. Chemerow (Director) | Bought (not open market) | $625K |
| Mar 6, 2026 | David I. Chemerow (Director) | Bought (not open market) | — |
| Mar 6, 2026 | Thomas K Equels (CEO) | Bought (not open market) | — |
| Feb 5, 2026 | David I. Chemerow (Director) | Bought (not open market) | $3.4K |
Who's trading AIM
- Thomas K Equels, CEO: other filings, last Mar 12, 2026
- David I. Chemerow, Director: other filings, last Mar 12, 2026
Get free alerts when an insider at AIM ImmunoTech Inc files a new trade →